On December 29, 2017, the signing ceremony for the investment of trace element biotechnology in the direct equity investment policy of the Guangzhou Development Zone, Huangpu District, Guangzhou was held in Guangzhou Biological Island! Director of Guangzhou Development Zone Finance Bureau Mei Shaocheng, Guangzhou High-tech Zone Investment Group Co., Ltd. Chairman of Guangzhou Guoju Venture Capital Co., Ltd. Gu Shang, General Manager of Guangzhou Guoju Venture Capital Co., Ltd. Lin Ruhai, Guangzhou Industrial Investment Fund Management Co., Ltd. Guangzhou Zhang Fan, Deputy General Manager of Science and Technology Financial Innovation Investment Holdings Co., Ltd., Liu Jihui, Chairman of Guangzhou Trace Element Biotechnology Co., Ltd. (hereinafter referred to as Trace Elements), Liu Yunxiang, General Manager of Trace Element Strategic Development Department, and Guangzhou Science and Technology Financial Innovation Investment Holdings The investment manager Huang Jin, trace element shareholder Rother Hua and other guests leaders attended the signing ceremony together.
At the signing ceremony, Guangzhou Development Zone, Huangpu District, Guangzhou City announced that it would invest 30 million yuan in trace elements through direct equity investment to become the company's new investment partner. It is understood that this investment is the implementation of financial support policies for the Guangzhou Development Zone to high-growth technology companies in the zone. Trace elements have become the beneficiaries of this policy due to their scientific and technological research and development strength and promising development trend.
With the development zone leaders giving a high degree of evaluation and recognition of the rapid development of trace elements in recent years, they have high expectations for the future development of trace elements, hoping that trace elements will fully grasp the good development of science and technology enterprises Opportunities, continue to strive to seize the commanding heights of scientific and technological research and development, create greater value for society, and become a benchmark enterprise in the field of biotechnology!